Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 9 Similar Profiles
Hot Flashes
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Placebos
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Peripheral Nervous System Diseases
Medicine & Life Sciences
Megestrol Acetate
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1983 2015
- 4 Finished
Survivorship research established investigator award
6/1/08 → 12/31/13
Project: Research project › Research Scientist Award
Survival Rate
Research Personnel
Mentors
Research
Organized Financing
CANCER CHEMOPREVENTION--ROLE OF INFECTION/IMMUNITY
6/1/99 → 3/31/05
Project: Research project › Research Project
Chemoprevention
Immunity
Skin Neoplasms
imiquimod
Infection
INHIBITION OF ORNITHINE DECARBOXYLASE BY ORAL COMPOUNDS
1/1/85 → 6/30/85
Project: Research project › Clinical Investigator Award (CIA)
Ornithine Decarboxylase
Skin
Tetradecanoylphorbol Acetate
Eflornithine
Retinoids
COMMUNITY CLINICAL ONCOLOGY PROGRAM
Loprinzi, C. L., Moertel, C. G., O'Connell, M., Moertel, C. G. & Moertel, C. G.
9/15/83 → 5/31/15
Project: Research project › Cooperative Clinical Research--Cooperative Agreements
Medical Oncology
Neoplasms
Research
Radiotherapy
Quality Control
Research Output 1982 2018
Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolism
Simmons, B., Wysokinski, W., Saadiq, R. A., Bott-Kitslaar, D., Henkin, S., Casanegra, A., Lenz, C., Daniels, P., Bjarnason, H., Vargas, E., Hodge, D., Holton, S. J., Cerhan, J. R., Loprinzi, C. & McBane, R., Aug 1 2018, In : European Journal of Haematology. 101, 2, p. 136-142 7 p.Research output: Contribution to journal › Article
Enoxaparin
Second Primary Neoplasms
Venous Thromboembolism
Safety
Low Molecular Weight Heparin
Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?
Cathcart-Rake, E., Smith, D., Zahrieh, D., Jatoi, A., Yang, P. & Loprinzi, C. L., May 24 2018, (Accepted/In press) In : Supportive Care in Cancer. p. 1-6 6 p.Research output: Contribution to journal › Article
Nose
Taxoids
Neoplasms
Vascular Endothelial Growth Factor A
Therapeutics
Oxybutynin for hot flashes due to androgen deprivation in men
Smith, T. J., Loprinzi, C. L. & Deville, C., May 3 2018, In : New England Journal of Medicine. 378, 18, p. 1745-1746 2 p.Research output: Contribution to journal › Letter
Hot Flashes
Androgens
oxybutynin
Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., Nguyen, L. H., Seigel, C. & Baile, W. F., Feb 1 2018, In : Obstetrical and Gynecological Survey. 73, 2, p. 96-97 2 p.Research output: Contribution to journal › Comment/debate
Consensus
Communication
Guidelines
Ten-year trends in antiemetic prescribing in patients receiving highly emetogenic chemotherapy
O’Sullivan, C. C., Van Houten, H. K., Sangaralingham, L. R., Leal, A. D., Shinde, S., Liu, H., Ettinger, D., Loprinzi, C. L. & Ruddy, K. J., Mar 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 3, p. 294-299 6 p.Research output: Contribution to journal › Article
Antiemetics
fosaprepitant
Drug Therapy
Neurokinin-1 Receptor Antagonists
Guidelines